Documents (986) JSON TSV

source DB	source ID	text	size	updated at	# proj.	# Ann.	updated_at
PubMed	25213700	Esophageal cancer stem cells express PLGF to increase cancer invasion through MMP9 activation. Cancer stem cells (CSCs) are a distinct population in tumors and cause cancer relapse and metastasis. Thu	1.49 KB	2016-01-20	7	23	-
PubMed	24929024	Targeting the genetic alterations of the PI3K-AKT-mTOR pathway: its potential use in the treatment of bladder cancers. Urothelial carcinoma of the bladder is the most frequent tumor of the urinary tra	1.7 KB	2016-01-17	8	11	-
PubMed	20857420	Thrombin induces expression of twist and cell motility via the hypoxia-inducible factor-1α translational pathway in colorectal cancer cells. Deep vein thrombosis associated with advanced cancer is kno	1.8 KB	2015-11-25	9	21	-
PubMed	24164897	Temporal production of the signaling lipid phosphatidic acid by phospholipase D2 determines the output of extracellular signal-regulated kinase signaling in cancer cells. The Ras-extracellular signal-	1.41 KB	2015-11-27	10	7	-
PubMed	19840121	Characterization of a mouse model overexpressing beta-site APP-cleaving enzyme 2 reveals a new role for BACE2. BACE2 is homologous to BACE1, a beta-secretase that is involved in the amyloidogenic path	1.02 KB	2015-11-25	8	4	-
PubMed	20470445	Tasquinimod (ABR-215050), a quinoline-3-carboxamide anti-angiogenic agent, modulates the expression of thrombospondin-1 in human prostate tumors. BACKGROUND: The orally active quinoline-3-carboxamide	1.85 KB	2015-11-25	9	12	-
PubMed	8630377	Multiple tumor-suppressor gene 1 inactivation is the most frequent genetic alteration in T-cell acute lymphoblastic leukemia. No constant genetic alteration has yet been unravelled in T-cell acute lym	2.01 KB	2015-11-27	8	7	-
PubMed	12002902	Screening for mutations in exons encoding the ligand-binding domain of the LDL receptor gene using PCR-CFLP and PCR-SSCP. Primary hypercholesterolemia includes both monogenic disorders and polygenic c	1.35 KB	2015-11-17	8	12	-
PubMed	24088574	The BCL2-938 C > A promoter polymorphism is associated with risk group classification in children with acute lymphoblastic leukemia. BACKGROUND: Acute lymphoblastic leukemia (ALL) is the most common p	1.32 KB	2015-11-26	10	4	-
PubMed	26505133	Metformin synergistically sensitizes FLT3-ITD-positive acute myeloid leukemia to sorafenib by promoting mTOR-mediated apoptosis and autophagy. Mutations of Fms-like tyrosine kinase 3-internal tandem d	1.25 KB	2016-01-25	7	5	-